PG director awarded 220 RSUs, ownership rises to 43,397.69 shares
Terry J. Lundgren, a director of Procter & Gamble (PG), was awarded 220 restricted stock units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan.
Rhea-AI Filing Summary
Terry J. Lundgren, a director of Procter & Gamble (PG), was awarded 220 restricted stock units (RSUs) on 09/09/2025 under the company's 2019 Stock and Incentive Compensation Plan. The RSUs were granted at a $0 per-share price as dividend-equivalent RSUs and are reported as 220 units added to his holdings. Following the transaction, Mr. Lundgren beneficially owns a total of 43,397.6912 shares, which includes RSU dividend equivalents and shares from the issuer's dividend reinvestment plan. Additionally, 530 shares are reported as indirectly held by his spouse.
Positive
- Director alignment: Receipt of 220 RSUs reinforces alignment of the director's interests with shareholders through equity compensation.
- Increased beneficial ownership: Total reported beneficial ownership of 43,397.6912 shares (including dividend reinvestment) indicates substantial existing stake.
Negative
- None.
Insights
TL;DR: Director received a modest RSU grant, increasing beneficial ownership to ~43.4k shares; includes dividend equivalents and spousal holdings.
The filing documents a non-cash equity award to a sitting director under the company's incentive plan, recorded as 220 RSUs. The grant price is reported as $0 because these units are dividend equivalents rather than an open-market purchase. The reporting aggregates multiple sources of ownership including dividend reinvestment plan shares, resulting in a total beneficial position of 43,397.6912 shares. Spousal indirect ownership of 530 shares is separately disclosed, consistent with Section 16 reporting rules.
TL;DR: Transaction is routine director compensation in equity form; it modestly increases insider stake but presents no cash flow or dilution signal.
The movement reflects a typical equity grant to align director interests with shareholders. The RSU grant size (220 units) is small relative to the reported total beneficial ownership, indicating a marginal change in insider exposure. The $0 price notation and explanatory text confirm these are dividend-equivalent RSUs and reinvested dividends, not an open-market acquisition. No derivative transactions or dispositions are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 220 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
- F2. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.
FAQ
What did Terry J. Lundgren report on Form 4 for PG?
What was the purchase or grant price for the RSUs?
Does the Form 4 report any derivative transactions or sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.